Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

ClearPoint Neuro Inc

CLPT
5,51
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
22/5/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202422:18EDGAR2Form S-8 - Securities to be offered to employees in employee..
16/5/202412:04EDGAR2Form 8-K - Current report
15/5/202415:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202415:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202415:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202415:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202423:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202422:05EDGAR2Form 8-K - Current report
07/5/202422:05GLOBEClearPoint Neuro Reports First Quarter 2024 Results
02/5/202422:05GLOBEClearPoint Neuro to Present Novel Research and Exhibit at..
29/4/202414:00GLOBEClearPoint Neuro Announces FDA Clearance of Prism Bone..
24/4/202422:05GLOBEClearPoint Neuro Announces Initiation of Limited Market..
23/4/202422:05GLOBEClearPoint Neuro to Announce First Quarter 2024 Results May..
16/4/202422:05GLOBEClearPoint Neuro Congratulates its Partner AviadoBio on..
19/3/202413:07GLOBEClearPoint Neuro Congratulates its Partner PTC Therapeutics..
12/3/202421:05GLOBEClearPoint Neuro Reports Fourth Quarter and Full-Year 2023..
11/3/202413:00GLOBEJournal of Neurosurgery Publication Demonstrates Distinct..
08/3/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:05GLOBEClearPoint Neuro to Announce Fourth Quarter and Full Year..
01/3/202414:00EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
29/2/202414:00GLOBEClearPoint Neuro Announces Pricing of Public Offering of..
28/2/202422:45GLOBEClearPoint Neuro Launches Proposed Public Offering of Common..
24/2/202400:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:05GLOBEClearPoint Neuro Announces FDA Clearance and First-in-Human..
06/2/202422:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24/1/202422:05GLOBEClearPoint Neuro Announces Installation and First Procedure..
22/1/202422:05GLOBEClearPoint Neuro Announces First EU MDR Certification..
16/1/202414:00GLOBEClearPoint Neuro Announces FDA Clearance for SmartFrame OR™..
08/1/202422:07EDGAR2Form 8-K - Current report
08/1/202422:05GLOBEClearPoint Neuro Reports Fourth Quarter and Full Year 2023..
04/1/202402:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202402:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202402:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202402:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202417:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202417:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
13/11/202315:22EDGAR2Form S-3 - Registration statement under Securities Act of..
09/11/202323:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apertura: Min: Max:
Chiusura: 5,51

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network